ADAMTS14 and nonpapillary renal cell carcinoma: All of the abovementioned results suggested that ccRCC patients with elevated ADAMTS14 expression might be more likely to progress to advanced stages and develop metastasis, compared with patients with low ADAMTS14 expression.